South and Central America Cancer Vaccines Market Share and Forecast by 2027
South and Central America Cancer Vaccines Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Technology (Dendritic Cells Cancer Vaccines, Recombinant Cancer Vaccines, Antigen Cancer Vaccines, Whole Cell Cancer Vaccines, Viral Vector Cancer Vaccines); Type (Preventive Cancer Vaccines, Therapeutic Cancer Vaccines); Indication (Cervical Cancer, Prostate Cancer, Other Indications); End User (Pediatrics, Adults), and Country
- Status : Published
- Report Code : TIPRE00015134
- Category : Life Sciences
- No. of Pages : 164
- Available Report Formats :
- Last update date : October 26, 2020
2019 Market Size
US$ 191.89 Mn
Base year value
2027 Forecast
US$ 627.49 Mn
Projected by 2027
CAGR 2020-2027
16.3 %
Growth rate
Addressable Market
US$ 3,213.16 Mn
(2020-2027)
The South and Central America cancer vaccines market was valued at US$ 191.89 million in 2019 and is projected to reach US$ 627.49 million by 2027; it is expected to grow at a CAGR of 16.3% during the forecast period.
The growth of the South & Central America Cancer Vaccines market is mainly attributed to the growing prevalence of cancer andinitiatives taken by global health organization.
Cancer is one of the primary epidemic diseases, and the number of people with cancer has become over double the number in the past three decades. According to data of an article, RevistaBrasileira de Cancerologia 2018, during 2018-2019, there would be approximately 600,000 new cases of cancer.
Brazil Cancer Vaccines Market Revenue and Forecast to 2027 (US$ Million)
SOUTH & CENTRAL AMERICA CANCER VACCINES – MARKET SEGMENTATION
By Technology
- Dendritic Cells Cancer Vaccines
- Recombinant Cancer Vaccines
- Antigen Cancer Vaccines
- Whole Cell Cancer Vaccines
- Viral Vector Cancer Vaccines
By Type
- Preventive Cancer Vaccines
- Therapeutic Cancer Vaccine
By Indication
- Cervical Cancer
- Prostate Cancer
- Other Indications
By End Use
- Pediatrics
- Adults
By Country
- Brazil
- Argentina
- RoSCAM
CompanyProfiles
- AstraZeneca
- GlaxoSmithKline plc.
- Aduro Biotech Inc
- Pfizer Inc.
- Sanofi
- Bristol-Myers Squibb
- Moderna, Inc.
- OncBioMune Pharmaceuticals Inc.
- MaxiVAX
- Nouscom
South and Central America Cancer Vaccines Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 191.89 Million |
| Market Size by 2027 | US$ 627.49 Million |
| CAGR (2019 - 2027) | 16.3% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Technology
|
| Regions and Countries Covered |
South and Central America
|
| Market leaders and key company profiles |
|
- Comprehensive Market Sizing and Forecast Analysis
- Detailed Segmentation Analysis
- In-Depth Market Dynamics Assessment
- Regional and Country-Level Insights
- Competitive Landscape and Company Benchmarking
- Strategic Business Intelligence
Recent Reports
Testimonials
The Insight Partners' SCADA System Market report is comprehensive, with valuable insights on current trends and future forecasts. The team was highly professional, responsive, and supportive throughout. We are very satisfied and highly recommend their services.
RAN KEDEM Partner, Reali Technologies LTDs
I requested a report on a very specific software market and the team produced the report in a few days. The information was very relevant and well presented. I then requested some changes and additions to the report. The team was again very responsive and I got the final report in less than a week.
JEAN-HERVE JENN Chairman, Future Analytica
We worked with The Insight Partners for an important market study and forecast. They gave us clear insights into opportunities and risks, which helped shape our plans. Their research was easy to use and based on solid data. It helped us make smart, confident decisions. We highly recommend them.
PIYUSH NAGPAL Sr. Vice President, High Beam Global
The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services
YUKIHIKO ADACHI CEO, Deep Blue, LLC.
This is the first time I have purchased a market report from The Insight Partners.While I was unsure at first, I visited their web site and felt more comfortable to take the risk and purchase a market report.I am completely satisfied with the quality of the report and customer service. I had several questions and comments with the initial report, but after a couple of dialogs over email with their analyst I believe I have a report that I can use as input to our strategic planning process.Thank you so much for taking the extra time and making this a positive experience.I will definitely recommend your service to others and you will be my first call when we need further market data.
JOHN SUZUKI President and Chief Executive Officer, Board Director, BK Technologies
I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.
DR CHIJIOKE ONYIA MANAGING DIRECTOR, PineCrest Healthcare Ltd.Reason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Identifying Emerging Markets
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Boosting Operational Efficiency
- Strategic Planning
- Investment Justification
- Tracking Industry Innovations
- Aligning with Regulatory Trends
Get Free Sample for